397 results on '"Kimby, Eva"'
Search Results
2. Diversity of intratumoral regulatory T cells in B-cell non-Hodgkin lymphoma
3. Treatment sequencing and impact of number of treatment lines on survival in follicular lymphoma: A national population‐based study
4. Genomic and microenvironmental landscape of stage I follicular lymphoma, compared with stage III/IV
5. Distinct clinical and genetic features of hepatitis B virus–associated follicular lymphoma in Chinese patients
6. Validation of POD24 as a robust early clinical end point of poor survival in FL from 5225 patients on 13 clinical trials
7. Outcomes of older patients with follicular lymphoma using individual data from 5922 patients in 18 randomized controlled trials
8. Short regimen of rituximab plus lenalidomide in follicular lymphoma patients in need of first-line therapy
9. High-risk chronic lymphocytic leukemia in the era of pathway inhibitors: integrating molecular and cellular therapies
10. Genetic and Microenvironment Features Do Not Distinguish Follicular Lymphoma Patients Requiring Immediate or Deferred Treatment
11. Molecular Monitoring after Autologous Stem Cell Transplantation and Preemptive Rituximab Treatment of Molecular Relapse; Results from the Nordic Mantle Cell Lymphoma Studies (MCL2 and MCL3) with Median Follow-Up of 8.5 Years
12. Survival by First-line Treatment Type and Timing of Progression Among Follicular Lymphoma Patients: A National Population-based Study in Sweden
13. Treatment recommendations from the Eighth International Workshop on Waldenström's Macroglobulinemia
14. Career development:A balance of opportunities and choices
15. Multi-Omics Profiling of Longitudinal Samples Reveals Early Genomic Changes in Follicular Lymphoma
16. Treatment Sequencing and Survival in Follicular Lymphoma: A National Population-Based Study
17. Managing high-risk CLL during transition to a new treatment era: stem cell transplantation or novel agents?
18. Treatment recommendations for patients with Waldenström macroglobulinemia (WM) and related disorders: IWWM-7 consensus
19. Nordic MCL3 study: 90Y-ibritumomab-tiuxetan added to BEAM/C in non-CR patients before transplant in mantle cell lymphoma
20. Prognostic role of SOX11 in a population-based cohort of mantle cell lymphoma
21. Diversity of Intratumoral Regulatory T Cells in Non-Hodgkin Lymphoma
22. Long-term outcomes to fludarabine and rituximab in Waldenström macroglobulinemia
23. TCL1A expression delineates biological and clinical variability in B-cell lymphoma
24. Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo–purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group
25. Outcome By Primary Treatment Type and Timing of Progression Among Follicular Lymphoma Patients: A Large, Population-Based Study in Sweden
26. Bortezomib in Combination with Dexamethasone, Rituximab and Cyclophosphamide (B-DRC) As First - Line Treatment of Waldenstrom's Macroglobulinemia: Results of a Prospectively Randomized Multicenter European Phase II Trial
27. Heterogeneity of Regulatory T Cells in B-Cell Non-Hodgkin Lymphoma
28. Double Hit Lymphoma Diagnosis and Treatment in Europe—A Cross-Sectional Survey of Clinical Practice by the EHA Lymphoma Working Party (EHA LyG)
29. ESMO Guidelines consensus conference on malignant lymphoma 2011 part 1: diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL)
30. Myeloablative allogeneic stem cell transplantation for lymphoblastic lymphoma in Sweden: A retrospective study
31. Increasing prevalence of chronic lymphocytic leukemia with an estimated future rise: A nationwide population‐based study
32. A Multistate Survival Analysis for Patients with Follicular Lymphoma (FL) Using 13 First-Line Randomized Trials from FL Analysis of Surrogate Hypothesis (FLASH) Group
33. Blood concentrations of alemtuzumab and antiglobulin responses in patients with chronic lymphocytic leukemia following intravenous or subcutaneous routes of administration
34. CAMPATH-1H therapy of patients with previously untreated chronic lymphocytic leukemia (CLL).
35. Waldenström’s macroglobulinaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
36. A clinico-molecular predictor identifies follicular lymphoma patients at risk of early transformation after first-line immunotherapy
37. The PRIMA-Prognostic Index (PI) Is Valid in Follicular Lymphoma (FL) Patients with Rituximab Chemo-Free First-Line Treatment
38. Continuous Increasing Prevalence of Chronic Lymphocytic Leukemia (CLL) with an Estimated Future Rise—a Nationwide Population-Based Study from Sweden
39. M7-FLIPI Not Valid in Follicular Lymphoma Patients with First-Line Rituximab Chemo-Free Therapy
40. First-line therapy in chronic lymphocytic leukemia: a Swedish nation-wide real-world study on 1053 consecutive patients treated between 2007 and 2013
41. Phase II trial of subcutaneous anti-CD52 monoclonal antibody alemtuzumab (Campath-1H) as first-line treatment for patients with B-cell chronic lymphocytic leukemia (B-CLL)
42. Guideline for the diagnosis, treatment and response criteria for Bing-Neel syndrome
43. Molecular Monitoring after Autologous Stem Cell Transplantation and Preemptive Rituximab Treatment of Molecular Relapse; Results from the Nordic Mantle Cell Lymphoma Studies (MCL2 and MCL3) with Median Follow-Up of 8.5 Years
44. Marginal zone lymphoma
45. Oligoclonal TCRBV Gene Usage in B-Cell Chronic Lymphocytic Leukemia: Major Perturbations Are Preferentially Seen Within the CD4 T-Cell Subset
46. Treatment recommendations for Waldenstrom macroglobulinemia from the Eighth International Workshop on WM
47. Follicular Lymphoma with Focus on Therapy.
48. Unmet needs in the scientific approach to older patients with lymphoma
49. Prognostic relevance of CD163 and CD8 combined with EZH2 and gain of chromosome 18 in follicular lymphoma: a study by the Lunenburg Lymphoma Biomarker Consortium
50. Follicular Lymphoma with Focus on Therapy in Advanced Stage Disease.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.